UMCG Cancer Research Fund grant awarded

Jacco de Haan and me have been awarded €42,000 from the UMCG Cancer Research Fund for the project: Towards use of gut microbiome analysis to predict tumor response of patient on immune checkpoint inhibitors: initiating a cohort of patients with advanced solid tumors as a critical first step. A big thanks and respect to all…

Genetic variants in RBFOX3 are associated with sleep latency

Eur J Hum Genet. 2016 May 4. Najaf Amin, Karla V Allebrandt, Ashley van der Spek, Bertram Müller-Myhsok, Karin Hek, Maris Teder-Laving, Caroline Hayward, Tõnu Esko, Josine G van Mill, Hamdi Mbarek, Nathaniel F Watson, Scott A Melville, Fabiola M Del Greco, Enda M Byrne, Edwin Oole, Ivana Kolcic, Ting-hsu Chen, Daniel S Evans, Josef…

Young Academy of Groningen

Proud to be selected as a member of the Young Academy of Groningen! The Young Academy of Groningen is a club for the University’s most talented, enthusiastic and ambitious young researchers of all fields and disciplines. Operating independently within the University, the Young Academy aims to actively promote interdisciplinary research engage the University’s young researchers…

Job opportunity / PhD-student

We are currently looking for a PhD-student! Have a look at the following link (you can apply by following this link): Job description at UMCG Working environment A PhD position for 4 years is available in the research group of dr. Rudolf Fehrmann, which is focused on integrative omics approaches to identify driver genomic alterations…

Rico Bense joins research group

I’m proud to announce that Rico Bense will join my research group. He has been granted a joint MD/PhD program by the Junior Scientific Masterclass (University Medical Center Groningen). His research proposal is titled: Identifying therapeutic targets and modulators of therapy efficacy in breast cancer subgroups. I’m looking forward to work with him the coming…

Veni grant awarded

I’m very proud to announce that I’ve been rewarded a Veni grant! Last week I’ve received the follow email from the Governing Board of NWO: The Governing Board of NWO reached a final decision on your application for the Veni programme. I am pleased to inform you that the Governing Board has decided to award…

Functional Genomic mRNA Profiling of a large cancer data base demonstrates mesothelin overexpression in a broad range of tumor types

Oncotarget. 2015 Jul 1. [Epub ahead of print] Laetitia E. Lamberts, Derk Jan A. de Groot, Rico D. Bense, Elisabeth G.E. de Vries, Rudolf S.N. Fehrmann The membrane bound glycoprotein mesothelin (MSLN) is a highly specific tumor marker, which is currently exploited as target for drugs. There are only limited data available on MSLN expression…